Oxymorphone in Dogs & Cats
Generic: Oxymorphone
Oxymorphone is a potent synthetic opioid agonist frequently utilized in veterinary medicine for the management of acute moderate to severe pain in both dogs and cats.
This medication is intended for dogs and cats.
Overview
Oxymorphone is a pure mu-opioid receptor agonist that serves as a cornerstone of clinical analgesia in hospital settings, often preferred for its rapid onset and relative lack of histamine release compared to morphine. It is classified as a Schedule II controlled substance, reflecting its high potential for abuse in humans and the necessity for strict clinical oversight. Veterinarians administer this drug primarily to manage perioperative pain or to address traumatic injuries, ensuring that patients remain comfortable during stressful diagnostic or surgical interventions. Because of its potency, it is widely regarded as a superior alternative to butorphanol for patients experiencing significant physical distress, particularly those undergoing orthopedic procedures such as hip dysplasia corrective surgeries. Clinical applications often involve multimodal analgesia, where oxymorphone is combined with local anesthetics like bupivacaine or ropivacaine to achieve comprehensive pain control while minimizing the total dose of opioids required. This balanced approach helps in managing systemic inflammation associated with conditions like heat stroke or severe musculoskeletal trauma. When managing long-term or chronic discomfort, veterinarians might eventually transition patients to oral medications such as gabapentin or amantadine, though oxymorphone remains strictly an injectable medication in the clinical environment. Clinicians must carefully titrate the dose based on the patient's individual pain assessment and physiological status, as respiratory depression is a known consequence of high-dose administration. Through its targeted action on the central nervous system, oxymorphone provides reliable sedation and pain relief, though it is rarely used alone for deep anesthesia unless combined with agents like ketamine. Proper monitoring of heart rate, respiratory rate, and blood pressure is mandatory for any patient receiving this medication, especially when the animal is already in a compromised health state.
What It Treats
- Acute post-operative pain
- Severe traumatic injury pain
- Procedural sedation for diagnostic imaging
- Pain associated with internal organ distress
- Severe anxiety related to painful physical conditions
How It Works
Oxymorphone functions primarily by binding to mu-opioid receptors within the central nervous system, which effectively modulates the transmission of pain signals. By mimicking the body's natural endorphins, it increases the threshold for pain perception and decreases the emotional response to painful stimuli. Unlike weaker opioids such as [codeine](/medications/codeine-in-dogs-and-cats), oxymorphone provides a robust analgesic effect that interrupts pain pathways at the spinal cord and brain levels. It also creates a degree of physical sedation, which assists in keeping patients calm during the critical post-injury or post-surgical period. The drug is highly lipid-soluble, allowing it to cross the blood-brain barrier effectively to exert its influence quickly after administration.
Dosage
Dosage is highly variable and must be determined exclusively by a licensed veterinarian based on the patient's weight, age, underlying health status, and the severity of the pain. It is never intended for home administration; you must strictly follow the dosing frequency and volume prescribed by your veterinary team.
Administration
Oxymorphone is strictly administered by veterinary professionals in a clinical setting via intravenous, intramuscular, or subcutaneous injection. The intravenous route is typically preferred for rapid onset during surgical induction, while intramuscular injections are often utilized for prolonged, steady-state pain management.
Storage
This medication must be stored in a secure, locked area consistent with regulations for Schedule II controlled substances. It should be kept at controlled room temperature, protected from direct sunlight, and maintained in its original packaging to ensure the stability of the chemical compound.
Contraindications
Oxymorphone should be avoided in animals with severe pulmonary disease, hypothyroidism, or adrenocortical insufficiency, as these conditions increase the risk of adverse respiratory or cardiac events. It is also contraindicated in patients suffering from head trauma or increased intracranial pressure, as the medication may exacerbate these conditions by impacting brain blood flow or respiratory function.
Interactions
Concurrent use of other central nervous system depressants, such as general anesthetics, tranquilizers, or sedatives, can lead to profound respiratory depression and cardiovascular collapse. Furthermore, the drug should not be administered alongside monoamine oxidase inhibitors (MAOIs) due to the risk of severe, life-threatening hypertensive or hypotensive reactions. If a patient is currently taking [fentanyl](/medications/fentanyl-in-dogs-and-cats) or [buprenorphine](/medications/buprenorphine-in-dogs-and-cats), these must be discontinued or managed carefully to avoid antagonistic effects or additive toxicity.
Side Effects
- Respiratory depression
- Bradycardia (slow heart rate)
- Nausea and vomiting
- Dysphoria or excitement in cats
- Pantin
- Sedation
- Constipation
- Potential for physical dependence
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
